News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Omicia, Inc. And University Of Utah Health Sciences Sign Agreement To Use Opal Platform To Analyze And Interpret Personal Genomes For The Clinic



12/4/2013 10:01:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OAKLAND, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Omicia, Inc., has announced a partnership with the University of Utah’s Utah Genome Project. Under a two-year licensing agreement with Omicia, the University will use and advance Opal, the company’s whole genome analysis platform for research and clinical applications. The agreement enables the University’s researchers and clinicians to use Opal on a cost-per-genome basis. Through the partnership, all researchers and clinicians at the University of Utah will have access to the Opal platform.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES